Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MIV-818 |
Trade Name | |
Synonyms | MIV818|MIV 818 |
Drug Descriptions |
MIV-818 is a prodrug that is hydrolyzed in hepatocytes to troxacitabine triphosphate (TRX-TP), which may have immune modulating and anti-tumor effects (Mol Cancer Ther 2019;18(12 Suppl):Abstract nr C056.). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C157496 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
MIV-818 | MIV-818 | 0 | 1 |